top of page

Two New Studies Reveal Indian Mangoes' Startling Metabolic Advantages

  • Writer: Anustup Kundu
    Anustup Kundu
  • Aug 7
  • 2 min read
ree

News Desk, News Nation 360 : The National Diabetes, Obesity and Cholesterol Foundation (N-DOC) in New Delhi and Fortis C-DOC Hospital for Diabetes and Allied Sciences, New Delhi, recently published two clinical studies that showed how a controlled intake of various Indian mangoes within restrictive diets may provide quantifiable benefits in glycaemic control and metabolic health among people with type 2 diabetes. Dr. Anoop Misra stated that for the first time, they demonstrated in two comprehensive studies the advantages of eating small amounts of mangoes for breakfast instead of carbs (bread), dispelling any myths about the detrimental metabolic implications of doing so. These must, however, be added to diets under the careful supervision of nutritionists—within recommended bounds and not in excess—and by the patient's clinical profile as determined by medical professionals. A decisive departure from traditional dietary advice for diabetes, exhaustive research spearheaded by Dr. Anoop Misra (Padma Shri, Executive Chairman & Director, Diabetes and Endocrinology, Fortis C-Doc Hospital) with Dr. Sugandha Kehar as lead author, ensures that mangoes can be incorporated in the diets of diabetics without any harm. Two significant studies support the results. The first one, published in the European Journal of Clinical Nutrition, compared 95 subjects (45 type 2 diabetic and 50 non-diabetic) with Oral Tolerance Tests (comparing 250 grams of three mango varieties of India—Safeda, Dasheri, and Langra—with calorically matched bread) and three-day Continuous Glucose Monitoring. Findings indicated mangoes induced identical or even lower blood sugar rises than bread in diabetics and non-diabetics, and, importantly, in diabetics, glycemic variation was considerably less after eating mango compared to bread, indicating enhanced glycemic stability. The second trial, in the Journal of Diabetes & Metabolic Disorders, was an eight-week randomised trial involving 35 adults with type 2 diabetes eating one small mango or equivalent white bread each day at breakfast. The mango groups experienced decreases in fasting blood glucose, HbA1c, insulin resistance, body weight, waist circumference, and skinfold thickness, along with significant increases in HDL (good cholesterol) levels. Collectively, this evidence-based study strongly advocates the safety and benefits of moderate mango integration into diabetic diets, refuting past limitations.


Pic - Courtesy



Read Next

Archive

bottom of page